BR112017028381A2 - agente para melhora da hiperatividade do músculo detrusor com contratilidade prejudicada - Google Patents

agente para melhora da hiperatividade do músculo detrusor com contratilidade prejudicada

Info

Publication number
BR112017028381A2
BR112017028381A2 BR112017028381-6A BR112017028381A BR112017028381A2 BR 112017028381 A2 BR112017028381 A2 BR 112017028381A2 BR 112017028381 A BR112017028381 A BR 112017028381A BR 112017028381 A2 BR112017028381 A2 BR 112017028381A2
Authority
BR
Brazil
Prior art keywords
detrusor muscle
agent
muscle hyperactivity
impaired contractility
improve
Prior art date
Application number
BR112017028381-6A
Other languages
English (en)
Japanese (ja)
Inventor
Hayashi Yukio
NOMA Takahisa
Original Assignee
Taiho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co., Ltd. filed Critical Taiho Pharmaceutical Co., Ltd.
Publication of BR112017028381A2 publication Critical patent/BR112017028381A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

a presente invenção refere-se ao problema que deve ser resolvido de fornecer um processo para o tratamento de hiperatividade do músculo detrusor com contratilidade prejudicada. a presente invenção fornece um processo para o tratamento de hiperatividade do músculo detrusor com contratilidade prejudicada, que contém 3-(15-hidroxipentadecil)-2,4,4-trimetil-2-ciclohexeno-1-ona, um sal do composto ou um solvato do composto ou o sal como um ingrediente ativo.
BR112017028381-6A 2015-08-04 2016-08-03 agente para melhora da hiperatividade do músculo detrusor com contratilidade prejudicada BR112017028381A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/817,318 2015-08-04
US14/817,318 US20170035705A1 (en) 2015-08-04 2015-08-04 Detrusor hyperactivity with impaired contractility ameliorating agent
PCT/JP2016/072753 WO2017022787A1 (ja) 2015-08-04 2016-08-03 収縮力低下随伴性排尿筋過活動改善剤

Publications (1)

Publication Number Publication Date
BR112017028381A2 true BR112017028381A2 (pt) 2018-08-28

Family

ID=57943093

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017028381-6A BR112017028381A2 (pt) 2015-08-04 2016-08-03 agente para melhora da hiperatividade do músculo detrusor com contratilidade prejudicada

Country Status (17)

Country Link
US (3) US20170035705A1 (pt)
EP (1) EP3332779B1 (pt)
JP (1) JP6328856B2 (pt)
KR (2) KR102076137B1 (pt)
CN (1) CN107921011A (pt)
AU (1) AU2016301689B2 (pt)
BR (1) BR112017028381A2 (pt)
CA (1) CA2994648C (pt)
ES (1) ES2836685T3 (pt)
HK (1) HK1247106A1 (pt)
MX (1) MX2018001518A (pt)
MY (1) MY197287A (pt)
PH (1) PH12018500176A1 (pt)
RU (1) RU2714444C2 (pt)
SG (1) SG11201710583RA (pt)
TW (1) TWI668005B (pt)
WO (1) WO2017022787A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6894555B1 (ja) * 2020-07-03 2021-06-30 大鵬薬品工業株式会社 排尿症状治療剤
JP2022013721A (ja) * 2020-07-03 2022-01-18 大鵬薬品工業株式会社 排尿症状治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69811905T2 (de) 1997-08-13 2003-11-06 Meiji Milk Prod Co Ltd Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
JP3836684B2 (ja) * 2001-02-19 2006-10-25 明治乳業株式会社 排尿障害治療剤
RU2193401C1 (ru) * 2001-04-02 2002-11-27 Аль-Шукри Салман Хасунович Способ лечения гиперактивности мочевого пузыря
US20080033018A1 (en) * 2004-07-05 2008-02-07 Chugai Seiyaku Kabushiki Kaisha Therapeutic Agents For Overactive Bladder
CA2595208C (en) * 2005-01-18 2013-04-23 Meiji Dairies Corporation Therapeutic agents for sensory disorders
JP2009292797A (ja) * 2008-06-09 2009-12-17 Kyoto Univ 過活動膀胱治療剤
JP2015067565A (ja) 2013-09-27 2015-04-13 大鵬薬品工業株式会社 ３−（１５−ヒドロキシペンタデシル）−２，４，４−トリメチル−２−シクロヘキセン−１−オン又はその塩を含有する医薬組成物
JP5566521B1 (ja) * 2013-09-27 2014-08-06 大鵬薬品工業株式会社 膀胱・尿道協調不全改善剤

Also Published As

Publication number Publication date
RU2714444C2 (ru) 2020-02-17
SG11201710583RA (en) 2018-01-30
EP3332779A1 (en) 2018-06-13
RU2018107515A (ru) 2019-09-05
TWI668005B (zh) 2019-08-11
PH12018500176A1 (en) 2018-07-30
CN107921011A (zh) 2018-04-17
AU2016301689B2 (en) 2018-10-04
CA2994648A1 (en) 2017-02-09
KR20190134825A (ko) 2019-12-04
ES2836685T3 (es) 2021-06-28
US20170035705A1 (en) 2017-02-09
RU2018107515A3 (pt) 2019-09-05
MY197287A (en) 2023-06-09
JPWO2017022787A1 (ja) 2018-04-26
JP6328856B2 (ja) 2018-05-23
CA2994648C (en) 2020-04-07
KR102076137B1 (ko) 2020-02-11
WO2017022787A1 (ja) 2017-02-09
TW201717924A (zh) 2017-06-01
KR20180038003A (ko) 2018-04-13
MX2018001518A (es) 2018-04-24
US9687457B2 (en) 2017-06-27
US20170252307A1 (en) 2017-09-07
AU2016301689A1 (en) 2018-01-25
EP3332779B1 (en) 2020-10-28
EP3332779A4 (en) 2019-03-13
HK1247106A1 (zh) 2018-09-21
US20170035706A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
CL2018000429A1 (es) Moduladores de la expresión de kras
CL2019001565A1 (es) Composición farmacéutica para prevenir o tratar el cáncer, comprendiendo el polímorfo cristalino del hexoxido tetraarsénico.
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
EA201791874A1 (ru) Фторированные ингибиторы лизилоксидазоподобного фермента-2 и их применение
CO2017013065A2 (es) Moduladores de diaciglicerol aciltransferasa 2 (dgat2)
BR112016014146A2 (pt) Métodos para formatar material fibroso e composições de tratamento para os mesmos
CL2020001742A1 (es) Inhibidores de glicolato oxidasa para el tratamiento de enfermedades
MX2017010544A (es) Metodos y composiciones para tratar la enfermedad del ojo seco y otros trastornos del ojo.
BR122020024446B8 (pt) Compostos para modulação da expressão do receptor do hormônio de crescimento
BR112017004953A2 (pt) imunoconjugado, formulação farmacêutica, método de tratamento e método de inibição da proliferação de uma célula
BR112016002757A2 (pt) peneira molecular beta que tem estrutura de canal de multinível e método de preparação da mesma
BR112016023815A2 (pt) composições tópicas para o alívio da dor, produção e uso
BR112019003731A2 (pt) aplicação de pridopidina para tratamento de distonias
BR112016021282A8 (pt) processos para a preparação de compostos antifúngicos e os referidos compostos
BR112018000776A2 (pt) métodos para tratamento de câncer usando apilimod
CO2020000227A2 (es) Moduladores de nlrp3
BR112018073944A2 (pt) uso de uma composição.
BR112019005040A2 (pt) aplicação de pridopidina para tratamento de síndrome de rett
CR20190471A (es) Moduladores de la expresión de pcsk9
BR112016028316A2 (pt) composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento
CL2016001763A1 (es) Antagonistas selectivos de nr2b
BR112017028381A2 (pt) agente para melhora da hiperatividade do músculo detrusor com contratilidade prejudicada
BR112016008267A2 (pt) Composição para prevenir ou tratar esclerose lateral amiotrófica usando duas ou mais isoformas de fator de crescimento de hepatócito
BR112018069174A2 (pt) tratamento de prurido urêmico
BR112017010836A2 (pt) emulsão pickering, particularmente uma emulsão cosmética, uso de um filossilicato sintético com fórmula molecular mg3si4o10(oh)2, processo para preparar uma emulsão e de tratamento cosmético

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]